Pure Global
NCT05032508

Efficacy of the Application of Xylocaine Impregnated Compress in Reducing Per-procedural Pain During Ultrasound-guided Infiltration of Trigger Finger

Efficacy of the Application of Xylocaine Impregnated Compress in Reducing Per-procedural Pain During Ultrasound-guided Infiltration of Trigger Finger: a Randomized, Double-blind Controlled Study (SAUTYLO)
Assistance Publique - Hôpitaux de Paris·Phase 4·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Trigger Finger
Drug/Device/Intervention
Lidocaïne Aguettant 20 mg/ml
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Assistance Publique - Hôpitaux de Paris
Location
Paris, France
Timeline & enrollment
Phase
Phase 4
Start date
Apr 01, 2022
End date
Apr 01, 2023
Enrollment
60 participants
Primary outcome

Average pain intensity during the ultrasound-guided infiltration.

Summary

The purpose of this study is to assess the efficacy of Xylocaine impregnated compress in
 reducing per-procedural pain during ultrasound-guided infiltration of Trigger Finger

ICD-10 classifications
Trigger fingerAccessory finger(s)Fused fingersAccessory thumb(s)Clubbing of fingers
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05032508
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05032508 through Pure Global AI's free database. This Phase 4 trial is sponsored by Assistance Publique - Hôpitaux de Paris and is currently Not yet recruiting. The study focuses on Trigger Finger. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.